Development of residency program guidelines for interaction with the pharmaceutical industry
Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the p...
Gespeichert in:
Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 1993-08, Vol.149 (4), p.405 |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 405 |
container_title | Canadian Medical Association journal (CMAJ) |
container_volume | 149 |
description | Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_204787686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>450577461</sourcerecordid><originalsourceid>FETCH-LOGICAL-p180t-dfa8a129d3bfa2cb7c48f5e08bd51fd59d53613b8bca1f3d9845035c51e16e363</originalsourceid><addsrcrecordid>eNotjk1LxDAYhIMoWFf_Q_BeyEeTpkdZP2HBi96EJU3ebLO0SU1SZf-9BXcuA8PDzFygijZK1Yyz7hJVRDFS866R1-gm5yNZxVlboa9H-IExzhOEgqPDCbK3EMwJzykekp7wYVmD0QfI2MWEfSiQtCk-Bvzry4DLAHgedJq0gaV4o8eVsUsu6XSLrpweM9ydfYM-n58-tq_17v3lbfuwq2eqSKmt00pT1lneO81M35pGOQFE9VZQZ0VnBZeU96o3mjpuO9UIwoURFKgELvkG3f_3rp-_F8hlf4xLCuvknpGmVa1Ukv8BhFRSUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204787686</pqid></control><display><type>article</type><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><description>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Ottawa: CMA Impact, Inc</publisher><subject>Medical personnel ; Medicine ; Pharmaceutical industry ; Physician relations ; Public health ; Study & teaching ; Training</subject><ispartof>Canadian Medical Association journal (CMAJ), 1993-08, Vol.149 (4), p.405</ispartof><rights>Copyright Canadian Medical Association Aug 15, 1993</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids></links><search><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title><title>Canadian Medical Association journal (CMAJ)</title><description>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</description><subject>Medical personnel</subject><subject>Medicine</subject><subject>Pharmaceutical industry</subject><subject>Physician relations</subject><subject>Public health</subject><subject>Study & teaching</subject><subject>Training</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNotjk1LxDAYhIMoWFf_Q_BeyEeTpkdZP2HBi96EJU3ebLO0SU1SZf-9BXcuA8PDzFygijZK1Yyz7hJVRDFS866R1-gm5yNZxVlboa9H-IExzhOEgqPDCbK3EMwJzykekp7wYVmD0QfI2MWEfSiQtCk-Bvzry4DLAHgedJq0gaV4o8eVsUsu6XSLrpweM9ydfYM-n58-tq_17v3lbfuwq2eqSKmt00pT1lneO81M35pGOQFE9VZQZ0VnBZeU96o3mjpuO9UIwoURFKgELvkG3f_3rp-_F8hlf4xLCuvknpGmVa1Ukv8BhFRSUA</recordid><startdate>19930815</startdate><enddate>19930815</enddate><general>CMA Impact, Inc</general><scope>4T-</scope><scope>4U-</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>19930815</creationdate><title>Development of residency program guidelines for interaction with the pharmaceutical industry</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p180t-dfa8a129d3bfa2cb7c48f5e08bd51fd59d53613b8bca1f3d9845035c51e16e363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Medical personnel</topic><topic>Medicine</topic><topic>Pharmaceutical industry</topic><topic>Physician relations</topic><topic>Public health</topic><topic>Study & teaching</topic><topic>Training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Docstoc</collection><collection>University Readers</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of residency program guidelines for interaction with the pharmaceutical industry</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><date>1993-08-15</date><risdate>1993</risdate><volume>149</volume><issue>4</issue><spage>405</spage><pages>405-</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><abstract>Medical residency programs are likely to face increasing pressure to address their relations with the pharmaceutical industry. Our internal medicine residency program has developed guidelines that were adopted after extensive debate by residents and faculty members. The guidelines are based on the principles that residents and faculty should set the educational agenda and that the residency program should not allow gifts of any sort from industry to residents. Specific policies include obtaining and screening educational materials from the industry before residents are exposed to them, proscribing "drug lunches" and accepting industry sponsorship only when the residency program maintains complete control of the educational event being sponsored. The industry response to the guidelines was split; about half reacted negatively, and half found the guidelines acceptable. Our experience suggests that productive debate about guidelines for the interaction of residency programs with the pharmaceutical industry is possible and desirable and that explicit policies can clarify areas of ambiguity.</abstract><cop>Ottawa</cop><pub>CMA Impact, Inc</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0820-3946 |
ispartof | Canadian Medical Association journal (CMAJ), 1993-08, Vol.149 (4), p.405 |
issn | 0820-3946 1488-2329 |
language | eng |
recordid | cdi_proquest_journals_204787686 |
source | PubMed Central; Alma/SFX Local Collection |
subjects | Medical personnel Medicine Pharmaceutical industry Physician relations Public health Study & teaching Training |
title | Development of residency program guidelines for interaction with the pharmaceutical industry |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T15%3A46%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20residency%20program%20guidelines%20for%20interaction%20with%20the%20pharmaceutical%20industry&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.date=1993-08-15&rft.volume=149&rft.issue=4&rft.spage=405&rft.pages=405-&rft.issn=0820-3946&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest%3E450577461%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204787686&rft_id=info:pmid/&rfr_iscdi=true |